Lessons Learned from Infants with Late Detection of Critical Congenital Heart Disease

Gerard R Martin1,2, Bryanna N Schwartz3,4, Lisa A Hom3,4

  • 1Division of Cardiology and The Children's National Heart Institute, Children's National Hospital, 111 Michigan Avenue, N.W., Washington, D.C., 20010, USA. gmartin@childrensnational.org.

Pediatric Cardiology
|October 28, 2021
PubMed

Insights

Late detection of critical congenital heart disease (CCHD) is often due to false-negative pulse oximetry screening (POS) or missed screenings. Improving prenatal ultrasounds, universal POS, and neonatal exams can prevent delayed CCHD diagnosis.

Area of Science:

  • Pediatrics
  • Cardiology
  • Neonatology

Background:

  • Late detection of critical congenital heart disease (CCHD) presents significant challenges.
  • The factors contributing to delayed diagnosis are not well-defined.

Purpose of the Study:

  • To investigate the outcomes of pulse oximetry screening (POS).
  • To identify points in the care chain that lead to delayed CCHD detection.

Main Methods:

  • Retrospective review of medical records for 13 infants with delayed CCHD detection (2013-2016).
  • Analysis of diagnoses, POS results, and clinical presentation at the time of detection.

Main Results:

  • Left heart obstructive lesions, particularly coarctation of the aorta, were the most common diagnoses.
  • Most infants (10/13) had false-negative POS results, and 3/13 had no POS performed.
  • The majority of infants (11/13) presented with significant clinical deterioration, with only 2 being asymptomatic.

Conclusions:

  • Late CCHD detection is uncommon but multifactorial.
  • Enhancing prenatal ultrasound detection, ensuring universal POS, and meticulous neonatal physical examinations are crucial for early diagnosis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.4K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
272
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
73
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
45